NutrientsOct 27, 2026

Using Targeted Nutrition to Influence the Microbe, Barrier, and Brain System in Long COVID Neurological Symptoms

Long Covid Weekly Brief ↗PubMed ↗DOI ↗OA ↗

Updated Oct 28, 2026

Abstract

Neuro-PASC is associated with cognitive impairment, chronic fatigue, dysautonomia, and neuropsychiatric symptoms contributing to Long COVID-related disability.

Persistent immune activation and intestinal barrier dysfunction may play a role in sustaining neuroinflammation and neurological impairment.
Dysbiosis of the gut microbiota and alterations in microbiome-derived metabolites could contribute to the pathogenesis of Neuro-PASC.
Key biomarkers, such as serum zonulin and faecal short-chain fatty acids, may assist in personalizing nutritional strategies for affected patients.
Proposed interventions include dietary stabilization, functional foods, targeted supplementation, and microbiome-based strategies.
Future research should focus on integrating multi-omics data, utilizing artificial intelligence, and conducting biomarker-stratified randomized controlled trials.

Simplified

Post-acute Neurological Sequelae of SARS-CoV-2 infection (Neuro-PASC) contribute substantially to Long COVID-related disability, with cognitive impairment, chronic fatigue, dysautonomia, and neuropsychiatric symptoms among its most debilitating manifestations. Although its pathogenesis remains incompletely understood, evidence implicates persistent immune activation, intestinal barrier dysfunction, microbiota dysbiosis, microbiome-derived metabolic alterations, mitochondrial dysfunction, and neuroimmune interactions in sustaining neuroinflammation and neurological impairment. This narrative review examines precision nutrition as a potential pathway-oriented strategy for Neuro-PASC. We synthesise evidence linking the gut microbiota, intestinal permeability, immunometabolic pathways, mitochondrial function, and neurological outcomes, while evaluating nutritional interventions targeting these mechanisms. We focus on candidate biomarkers, including serum zonulin, fatty acid-binding protein 2 (FABP2), faecal short-chain fatty acids (SCFAs), and the kynurenine-to-tryptophan ratio, which may support patient stratification and personalised nutritional strategies. We also propose a stepwise framework involving dietary stabilisation, functional foods, targeted supplementation, and microbiome-based interventions, alongside practical considerations for post-exertional symptom exacerbation, dysautonomia, and mast cell-related symptoms. Finally, we identify priorities for future research, including multi-omics integration, artificial intelligence, digital health, and biomarker-stratified randomised controlled trials. Because current evidence remains predominantly observational and mechanistic, precision nutrition should be considered a complementary strategy requiring rigorous clinical validation.

Full Text

Full text is available at the source.

View Full Text ↗

Using Targeted Nutrition to Influence the Microbe, Barrier, and Brain System in Long COVID Neurological Symptoms

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

What Lands in Your Inbox Each Week:

Recent issues from the long covid brief